Chronic lymphocytic leukaemia trials in United States

In United States 186 Also abroad 309

186 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Q702 for the Treatment of Patients With Hematologic Malignancies
Where
Rochester, Scottsdale
Age
18 years and over
People
46
Run by
Mayo Clinic
See details and how to joinNCT06712810
Phase 1Taking people
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Where
Chapel Hill, Cleveland, Columbus, Dallas, Denver, Nashville, Portland, Sarasota, Seattle
Age
18 years and over
People
60
Run by
Accutar Biotechnology Inc
See details and how to joinNCT05780034
No phaseTaking people
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
Where
New Hyde Park
Age
18 years and over
People
50
Run by
Northwell Health
See details and how to joinNCT05643235
Early phase 1Not yet taking people in United States
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Where
Columbus
Age
Up to 30 years
People
12
Run by
Nationwide Children's Hospital
See details and how to joinNCT05779930
Phase 2Taking people
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
Where
Cincinnati
Age
18 years and over
People
34
Run by
Zulfa Omer
See details and how to joinNCT06978088
Phase 1Taking people
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Where
Boston, Durham
Age
18 years and over
People
18 worldwide
Run by
Catapult Therapeutics
See details and how to joinNCT04704323 · EU 2024-516341-39-00
Phase 1Taking people
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Where
Boston, Duarte, Minneapolis, New York, Seattle
Age
18 years and over
People
36
Run by
Tr1X, Inc.
See details and how to joinNCT06462365
Phase 1Taking people
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
Where
Boston, Canton, Charlotte, Cleveland, Duarte, Jacksonville, Seattle
Age
18 years to 85 years
People
144 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT04215809
No phaseTaking people
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Where
Milwaukee
Age
18 years and over
People
300
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06788639
Phase 2Taking people
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Where
Pittsburgh
Age
18 years to 79 years
People
30
Run by
John Lister
See details and how to joinNCT05281809
Phase 1/2Taking people
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Where
Cincinnati, Columbus, Dallas, Goshen
Age
18 years and over
People
84 worldwide
Run by
Kartos Therapeutics, Inc.
See details and how to joinNCT04502394